Hemogenyx Pharmaceuticals (STU:5HU0) OCF Margin %: 0.00% (As of Dec. 2025)


STU:5HU0 Hemogenyx Pharmaceuticals PLC STU:5HU0
35 GF Score
Price €8.65
! 2 Warning Signs
View Full Analysis

What is Hemogenyx Pharmaceuticals OCF Margin %?

Hemogenyx Pharmaceuticals STU:5HU0 -5.46% 35 OCF Margin % is 0.00% as of Dec. 2025. GuruFocus rates STU:5HU0 with a GF Score™ of 35/100. The stock has 2 warning signs investors should review. Among 960 Biotechnology companies, Hemogenyx Pharmaceuticals ranks worse than 104166.56% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Hemogenyx Pharmaceuticals's Cash Flow from Operations for the six months ended in Dec. 2025 was €0.38 Mil. Hemogenyx Pharmaceuticals's Revenue for the six months ended in Dec. 2025 was €0.00 Mil. Therefore, Hemogenyx Pharmaceuticals's OCF Margin % for the quarter that ended in Dec. 2025 was 0.00%.

As of today, Hemogenyx Pharmaceuticals's current OCF Yield % is -6.19%.

The historical rank and industry rank for Hemogenyx Pharmaceuticals's OCF Margin % or its related term are showing as below:


STU:5HU0's OCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -68.59
* Ranked among companies with meaningful OCF Margin % only.

Hemogenyx Pharmaceuticals OCF Margin % Related Terms

Hemogenyx Pharmaceuticals OCF Margin % Historical Data

* Premium members only.

The historical data trend for Hemogenyx Pharmaceuticals's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hemogenyx Pharmaceuticals OCF Margin % Chart

Hemogenyx Pharmaceuticals Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Hemogenyx Pharmaceuticals Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
STU:5HU0
35GF Score
Hemogenyx Pharmaceuticals PLC STU:5HU0
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hemogenyx Pharmaceuticals OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Hemogenyx Pharmaceuticals's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-3.942/0
= %

Hemogenyx Pharmaceuticals's OCF Margin for the quarter that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=0.383/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
Hemogenyx Pharmaceuticals (STU:5HU0) has a OCF Margin % of 0.00% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Hemogenyx Pharmaceuticals and its competitors. According to the industry distribution chart, Hemogenyx Pharmaceuticals ranks #999999 out of 960 companies in the Biotechnology industry.
Is Hemogenyx Pharmaceuticals' OCF Margin % too high?
Hemogenyx Pharmaceuticals' current OCF Margin % is 0.00%. Based on the distribution chart, Hemogenyx Pharmaceuticals ranks #999999 out of 960 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Hemogenyx Pharmaceuticals has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does Hemogenyx Pharmaceuticals' OCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Hemogenyx Pharmaceuticals ranks #999999 out of 960 companies for OCF Margin %. This places Hemogenyx Pharmaceuticals in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Hemogenyx Pharmaceuticals and its competitors. Hemogenyx Pharmaceuticals's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hemogenyx Pharmaceuticals stock overvalued right now?
Hemogenyx Pharmaceuticals (STU:5HU0) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Hemogenyx Pharmaceuticals' overall GF Score™ is 35/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Hemogenyx Pharmaceuticals (STU:5HU0), the current OCF Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Hemogenyx Pharmaceuticals Business Description

Other Exchanges HEMO:UK
Address 6 Heddon Street, London, GBR, W1B 4BT
Hemogenyx Pharmaceuticals PLC is clinical-stage biotechnology focused on the discovery, development and commercialisation of treatments relating to the treatment of blood cancers, certain solid cancers, autoimmune diseases, and viral infections. The products under development are designed to address a range of problems that occur with current standard of care treatments. The Group has one reportable segment, the discovery, development, and commercialisation of treatments relating to blood and immune system disorders and viral infections, and administrative functions in the United Kingdom. It has its presence in United Kingdom; and United States.
35GF Score

Get the complete analysis for STU:5HU0

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€8.65
Price